Success in the fluorescence guided surgery market requires sophisticated business strategies that integrate technological innovation, clinical evidence generation, regulatory navigation, and commercial execution into coherent value propositions. Market entry strategies must balance first-mover advantages against follower benefits, with pioneers bearing clinical validation costs while...